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Abstract Trichothiodystrophy (TTD) is a rare, autoso-
mal recessive nucleotide excision repair (NER) disorder
caused by mutations in components of the dual
functional NER/basal transcription factor TFIIH. TTD
mice, carrying a patient-based point mutation in the Xpd
gene, strikingly resemble many features of the human
syndrome and exhibit signs of premature aging. To
examine to which extent TTDmice resemble the normal
process of aging, we thoroughly investigated the bone
phenotype. Here, we show that female TTD mice
exhibit accelerated bone aging from 39 weeks onwards
as well as lack of periosteal apposition leading to
reduced bone strength. Before 39 weeks have passed,
bones of wild-type and TTD mice are identical
excluding a developmental defect. Albeit that bone
formation is decreased, osteoblasts in TTD mice retain
bone-forming capacity as in vivo PTH treatment leads
to increased cortical thickness. In vitro bonemarrow cell
cultures showed that TTD osteoprogenitors retain the
capacity to differentiate into osteoblasts. However, after
13 weeks of age TTD females show decreased bone
nodule formation. No increase in bone resorption or the
number of osteoclasts was detected. In conclusion, TTD
mice show premature bone aging, which is preceded by
a decrease in mesenchymal stem cells/osteoprogenitors
and a change in systemic factors, identifying DNA
damage and repair as key determinants for bone fragility
by influencing osteogenesis and bone metabolism.
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Introduction
Trichothiodystrophy (TTD) is a rare, autosomal reces-
sive DNA repair disorder in which patients present an
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array of symptoms, including Photosensitivity, Ichthyo-
sis, Brittle hair and nails (hallmark feature), Impaired
intelligence, Decreased fertility, Short stature (hence,
the acronym PIBIDS) and a severely reduced life
span (Andressoo and Hoeijmakers 2005; Bootsma et
al. 1998; Botta et al. 1998; Faghri et al. 2008; Itin et
al. 2001). In addition, skeletal abnormalities, i.e.,
osteopenia in long bones and osteosclerosis in
vertebrae, have been described (Chapman 1988;
Civitelli et al. 1989; Itin et al. 2001; Kousseff and
Esterly 1988; McCuaig et al. 1993; Price et al. 1980;
Przedborski et al. 1990; Toelle et al. 2001; Wakeling
et al. 2004). A significant proportion of TTD patients
exhibit marked photosensitivity, due to impaired
repair of UV-induced DNA lesions. Complementation
analysis of UV-sensitive TTD patients revealed the
involvement of three repair genes (XPB, XPD and
TTDA), encoding subunits of the dual functional DNA
repair/basal transcription factor TFIIH (Giglia-Mari et
al. 2004). This 10-subunit protein complex is involved
in the nucleotide excision repair (NER) pathway, as
well as in the initiation of transcription by RNA
polymerases I and II (Chalut et al. 1994; Hashimoto
and Egly 2009; Hoeijmakers et al. 1996; Hwang et
al. 1996; Seroz et al. 1995; Svejstrup et al. 1996).
NER consists of a complex ‘cut-and-patch’ type
reaction involving ~30 proteins and is comprised of
two sub-pathways, differing in the initial steps of DNA
damage recognition (Gillet and Scharer 2006). Global
genome NER removes a wide class of helix-distorting
DNA damage (e.g., UV-induced photoproducts) from
the overall genome (Sugasawa 2010). This pathway is
primarily important for preventing DNA damage-
induced mutations and thereby for preventing cancer.
The second sub-pathway called transcription-coupled
NER focuses on the preferential excision of lesions in
the transcribed strand of active genes that actually
block transcription elongation, to allow rapid resump-
tion of arrested gene expression and thereby promoting
cell survival after genotoxic stress (Hanawalt 2002;
Hoeijmakers 2001). This sub-pathway is thought to
counteract the cytotoxic consequences of DNA dam-
age. TFIIH is as DNA helix opener implicated in both
NER sub-pathways as well as in transcription initiation
by promoter opening to allow the RNA polymerase to
get hold of the transcribed strand for transcription
elongation.
We have generated a mouse model in which we
precisely mimicked a causative point mutation in the
essential XPD gene of a TTD patient (TTD1BEL,
mutation at the protein level R722W) (de Boer et al.
1998). TTD mice have a phenotype that strikingly
resembles the symptoms of TTD patients and they
were found to exhibit several premature aging-like
features. Although TTD was not recognized as a
segmental premature aging syndrome, some of the
features observed in the mouse model were also
incidentally reported in patients: deterioration of
renal, liver and heart tissues, lymphoid depletion,
reduced hypodermal fat, aortic sarcopenia, skeletal
abnormalities and a (in patients strongly, in mice
moderately) reduced life span (Chapman 1988; Civitelli
et al. 1989; de Boer et al. 2002; Kousseff and Esterly
1988; Leupold 1979; McCuaig et al. 1993; Price et al.
1980; Przedborski et al. 1990; Toelle et al. 2001;
Wakeling et al. 2004; Wijnhoven et al. 2005).
Concerning skeletal aging, Price and co-workers
reported a patient who at the age of 7 years showed
decreased bone density in the distal bones on roent-
genographic examination (Price et al. 1980). Chapman
reported a 5-year-old child who exhibited decreased
bone density in the distal limbs and osteopenia in the
most distal parts (Chapman 1988).
Recent studies suggest that aging and the associated
increase in reactive oxygen species (ROS) may account
for the increased bone resorption associated with
the acute loss of estrogens or androgens rather than
estrogen deficiency per se (Manolagas 2010 and
references therein). Loss of these hormones decreases
defence against oxidative stress in bone while ROS
greatly influence the generation and survival of osteo-
clasts, osteoblasts, and osteocytes (Manolagas 2010 and
references therein). Forkhead box O (FoxO) transcrip-
tion factors defend against oxidative stress by activat-
ing genes involved in free radical scavenging and
apoptosis. Recently, it was shown that loss of FoxO
transcription factors leads to an increase in oxidative
stress and consequently osteoblast apoptosis with an
osteoporotic phenotype characterized by decreased
bone mass at both cancellous and cortical sites as
a result (Ambrogini et al. 2010) and specifically
deletion of FoxO1 in osteoblasts decreased osteoblast
numbers, bone formation rate, and bone volume
(Rached et al. 2010).
Thus, the TTD mouse could be a model for bone
fragility, which is observed in both aging women and
men. Whereas postmenopausal women show an
accelerated loss of predominantly trabecular bone,
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due to increased number and activity of osteoclasts, in
bone fragility both women and men show a slow
continuous phase of decrease in bone mass in which
the density of trabecular bone reduces and cortical
bone thins (Chan and Duque 2002; Harada and Rodan
2003; Kawaguchi et al. 1999; Riggs et al. 2002;
Seeman 2002). This is partly counteracted by
increased periosteal apposition (Seeman 2001), i.e.,
bone formation on the outside of the bone (periosteum),
a critical process that continues throughout life
(Riggs et al. 2002; Seeman 2002, 2003a). Periosteal
apposition is thought to be a response to the loss of
trabecular bone as well as endosteal resorption and
aims to maintain bone strength by increasing the
bone perimeter (Russo et al. 2006). The mechanisms
underlying these age-related changes are poorly
understood.
To assess the contribution of deficiencies in DNA
repair/basal transcription in skeletal aging and to
determine to which extent the progeroid features in
the mouse and human disorder truly reflect bona fide
aging, we decided to thoroughly examine the skeletal
aging as this process has been amply characterized in
normal aging. The TTD mouse model may provide a
unique tool to study aging and bone metabolism and
to assess the impact of DNA repair on skeletal aging.
Materials and methods
Mice and bones
The cohort of wild-type and TTD mice included eight
female animals per age group per genotype. Mice were
sacrificed at 13-week intervals up to an age of 104 and
78 weeks for wild-type and TTD mice, respectively. All
mice were on a C57BL/6J background, maintained on a
12:12 h light–dark cycle and fed ad libitum with ‘rat and
mouse breeder and grower diet’ from Special Diet’s
Services (minimal 0.5% Ca and 0.3% Pi). The animals
were injected intraperitoneal with calcein (10 μg/g body
weight) 10 and 3 days before sacrifice in order to study
the bone formation occurring in 1 week. After anaes-
thetization with isoflurane, blood was collected by an
orbital puncture; subsequently the mice were killed by
cervical dislocation. Femurs and tibiae were isolated
and were either used immediately for bone marrow
isolation, snap frozen in liquid nitrogen and stored
at −80°C or fixed in Burkhardt, which was replaced
by 70% ethanol after 3 days. There was no
significant difference in bone length between wild-
type and TTD mice (data not shown). As required
by Dutch law, formal permission to generate and
use genetically modified animals was obtained from the
responsible local and national authorities. All animal
studies were approved by an independent Animal Ethics
Committee (Dutch equivalent of the IACUC).
Micro-computed tomography
Fixed tibiae from wild-type and TTD mice of
different ages (n=4–6 per group) were scanned by
micro-computed tomography (μCT) from proximal
end to mid-diaphysis using the SkyScan 1072 micro-
tomograph (SkyScan, Antwerp, Belgium) with a voxel
size of 8.82 μm. The reconstructed data sets were
segmented using an automated algorithm based on local
thresholds (Waarsing et al. 2004). Three-dimensional
(3D) morphometric analysis of the bone was performed
using subsequent software packages, including Nrecon,
CT-analyze and Dataviewer (http://www.skyscan.be/
products/downloads.htm) and freely available software
of the 3D-Calculator project (http://www.erasmusmc.
nl/orthopaedie/research/labor/downloads). For all mice
a standardized metaphyseal–diaphyseal area (3.7–
6.9 mm from the proximal end; mainly consisting of
cortical bone) and a metaphyseal area (100 sections
starting 30 sections below our offset landmark within
the epiphyseal growth plate; including more trabecular
bone) were selected for analysis. It was previously
shown that murine femur length does not increase after
26 weeks of age (Glatt et al. 2007). We determined the
following parameters: cortical bone volume, 3D
thickness distribution (Hildebrand et al. 1999), cortical
thickness, periosteal perimeter, endocortical volume,
trabecular bone volume fraction (BV/TV), trabecular
number and trabecular thickness. Polar moment of
inertia (measure of the geometrical distribution and a
proxy for mechanical stiffness and strength per
transverse cross-section) was determined to analyze
the consequence of differences in geometry. The 3D
thickness distribution graph is similar to a usual
frequency distribution, only with infinitely small bins.
It is a continuous equivalent, similar to a probability
density distribution in statistics. While with discrete
bins the y-axis would show volume (fraction), this
continuous case narrows it down to volume density
(volume/μm).
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Histomorphometric analysis
To assess the dynamic histomorphometric indices,
mice received intraperitoneal injections with calcein
10 and 3 days prior to sacrifice. One tibia of each
mouse was dehydrated in ascending alcohol concen-
trations and embedded in polymethylmetacrylate
(PMMA) as described previously (Amling et al.
1999). Sections of 5 μm were cut in the sagittal plane
defined by the frontal aspect of the tibia and the fibula
on a Microtec rotation microtome (Techno-Med,
Munich, Germany). Consecutive serial sections are
cut in this plane and the section with the widest
diameter is used for analysis, thereby minimizing
potential artifacts. Subsequently, the sections were
stained by toluidine blue, van Gieson/von Kossa and
Giemsa procedures as described (Amling et al. 1999).
Parameters of static and dynamic histomorphom-
etry were quantified on these undecalcified proximal
tibia sections. For each animal, the bone formation
rate was determined by fluorochrome (calcein)
measurements using two non-consecutive 12-μm
sections per animal.
Analysis of osteocyte number per bone area (per
square millimeter), osteoblast number per bone peri-
meter (per millimeter), osteoclast number per bone
perimeter (per millimeter), osteoid volume per bone
volume (percentage), osteoid surface per bone surface
(percentage) was carried out according to standardized
protocols (Parfitt et al. 1987) using the OsteoMeasure
histomorphometry system (Osteometrics Inc., Atlanta,
GA, USA).
Mechanical testing
Defrosted femurs from 13-, 26-, 52- and 78-week-
old wild-type and TTD females as well as from
104-week-old wild-type females (5–8 mice/group)
were excised from the soft tissues. Femurs were
tested in a three-point bending assay using a Lloyd
LRX mechanical test frame, constructed with 3 mm
hemi-cylindrical supports with a 9-mm total span.
The femurs were aligned such that the neutral axis
was parallel to the sagittal plane (i.e., the femoral
head was in the horizontal plane and the posterior
aspect of the condyles were facing down). The
lesser trochanter was used as a reference point and
aligned with one of the two supports. All samples
were preconditioned for 5 cycles to 2 N at a rate of
0.01 mm/s before testing to failure at a rate of
0.02 mm/s.
Backscatter scanning electron microscopy
Processing and analyses were done as described
previously (Broderick et al. 2005). In short, from
each group (i.e., 26-, 52- and 78-week-old wild-type
and TTD mice) the distal halves of the femurs used
for mechanical testing were embedded in blocks of
MMA, such that each block contained one distal
femur from each genotype and age group. Within a
block, all femurs were placed within a plane, such
that the longitudinal lateral–medial plane of the
femurs coincided with the plane of embedding.
Embedding several samples in one block enabled us
to image these samples within one scanning electron
microscopy (SEM) session, thus decreasing the
variance in the measurements.
After embedding, the blocks were cut in two on an
electric band saw (Exakt, Norderstedt, Germany),
resulting in a slab of plastic with two parallel surfaces,
parallel to the plane of embedding of the femurs.
Starting from the posterior side of the bones, material
was removed using an automatic grinding system
(Buehler Phoenix 4000) with p400 grid paper until an
interior surface, halfway between the ventral and
dorsal external surfaces, was exposed. To reduce the
roughness of the surface the blocks were ground with
p1200 paper followed by polishing using 3 μm
diamond paste with polishing paper (Buehler Texmet
1000). The resulting surface had a roughness (Ra)
smaller than 0.05 μm. The blocks were cleaned,
sonicated and sputter coated with a thin layer of
carbon (Bio-Rad Temcarb Carbon Coater, Bio-Rad
Microscience Division) to enable conduction of the
electron beam to the sample surface.
Backscatter SEM images were taken of trabecular
bone of the metaphyseal and epiphyseal regions of
each bone sample, and of the cortex using methods
described in detail previously (Broderick et al. 2005).
The images were taken at an accelerating voltage of
25 kV, a working distance of 17 mm and 50×
magnification. Before and after imaging calibration
images were taken of an aluminum standard embed-
ded in each block and of the MMA material. The
equivalent Z value (atomic number) of the MMA was
obtained by calibration with aluminum (Z=13) and
carbon (Z=6) standards (Micro Analysis Consultants).
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From each image, the histogram of equivalent Z
values was calculated of which the mean value
represented the mean mineralization of the bone
tissue (Roschger et al. 1998).
Tartrate-resistant acid phosphatase assay
Bone resorption was determined by measuring serum
tartrate-resistant acid phosphatase (TRAP) levels
using the TRAP assay purchased from SBA Sciences
(Turku, Finland).
Bone marrow isolation, cell culture and cell culture
staining
Bone marrow was collected by spinning down the bone
marrow into an Eppendorf tube at 5,000 rev/min for
2 min immediately after obtaining the bones from the
mice. Erythrocytes were lysed using erylysis buffer
(1.55 M NH4Cl, 0.1 M KHCO3, 1 mM EDTA (10×))
and cells were washed and seeded at 1,000,000 cells/
well (12 wells) for osteoblasts, 100,000 cells/well
(96 wells) for osteoclasts and 750,000 cells/well, for
adipocytes (24 wells). For osteoblast cultures the
cells were cultured in phenol-red free α-minimal
essential medium (Gibco BRL), supplemented with
100 units/ml penicillin, 100 μg/ml streptomycin
(Life Technologies, Breda, the Netherlands),
250 ng/ml amphotericin B (Sigma), 20 mM Hepes,
1.8 mM CaCl2, and 15% (vol/vol) heat-inactivated
FCS (Gibco BRL), pH 7.5. From day 3 onward, the
culture medium was supplemented with 50 μM
vitamin C (Sigma) and 10 mM β-glycerophosphate
(Sigma). At days 14 and 21 of culture, cells were
fixed in 70% ethanol and stained for alkaline
phosphatase (ALP) and alizarin red, respectively.
For ALP staining, cells were incubated in Tris–HCL
(pH 9.5) containing 50 mM MgCl2, 0.6 mg/ml
bromo-chloro-indoryl phosphate (Sigma), and
150 μg/ml nitro blue tetrazolium (Sigma) for
20 min and washed with PBS. Alizarin red staining
was performed, incubating the cells for 10 min in a
saturated alizarin red S solution in distilled water
(pH 4.2), after which the cells were washed with
distilled water. Osteoblast colony-forming potential
and mineralisation potential were determined as
previously described after 14 and 21 days, respec-
tively, of culture (van der Eerden et al. 2005).
Colonies were counted by eye, plates were scanned
and colony surface area was determined by computer
analysis (Bioquant software). Alizarin Red staining
was quantified after extraction and measured at
405 nm on a plate reader.
Osteoclasts were cultured as previously described
(van der Eerden et al. 2005). Shortly, cells were
cultured for 6 days in the presence of 30 ng/ml
recombinant M-CSF (R&D Systems) and 20 ng/ml
recombinant murine RANKL-TEC (R&D Systems),
and the media were refreshed at day 3. At the end of
the human and murine cultures, cells were washed
with PBS, fixed in PBS-buffered paraformaldehyde
(4% vol/vol) or formalin (10% vol/vol), respectively,
and stored at 4°C for TRAP staining and immunocy-
tochemistry. Bone resorption was analyzed using the
resorption pit assay. Osteoclasts were cultured on
bovine cortical bone slices, after 6 days of culture the
cells were lysed in water and the bone slices were
sonicated in 10% (vol/vol) ammonia (Merck) for
10 min. After extensive washing, the cells were
incubated in filtered potassium aluminum sulfate
(Sigma) for 10 min and subsequently stained with
filtered Coomassie brilliant blue (Phastgel Blue R;
Amersham Pharmacia Biotech) for 5 s. Osteoclast
number and resorption capacity were determined as
previously described (van der Eerden et al. 2005) and
analyzed using freely available Image J software
(version 1.41; http://rsbweb.nih.gov/ij/).
Adipocytes were cultured on adipogenic (DMEM
[Gibco, Paisley, UK] supplemented with P/S, amphoter-
icin B [250 ng/ml, Sigma] and 15% heat-inactivated
FCS [Gibco]) medium. Adipogenesis was induced after
a 3-week expansion phase by adding insulin (0.1 μg/ml,
Sigma), indomethacin (1 mM, Sigma) and dexametha-
sone (1×10−7 M, Sigma) for 2 weeks.
Adipocyte cultures were fixated O/N with 10%
formaline, washed with 60% IPOH and stained with
Oil-Red O solution (60:40 dilution of Oil-Red O stock
solution (Clin-Tech limited) in H2O) after which the
total amount of adipocytes per well was determined.
PTH treatment
Twenty TTD females were weighed at the age of
45 weeks and randomly divided into two groups (n=10
per group): (1) subcutaneous injection with human
parathyroid hormone(1–34) (Bachem, Germany)
(40 μg/kg body weight) in a weekly alternating regimen
(PTH); (2) subcutaneous injection with phosphate-
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buffered saline in a weekly alternating regimen (VEH).
Animals were weighed at the start of every injection
week. At 65 weeks of age, animals were sacrificed and
femurs were prepared for μCT scanning.
Statistics
Micro-CT parameters, histomorphometric data, femur
length, ultimate load, bone resorption and mineraliza-
tion data and parameters of cell culture analyses were
compared between the age groups (significance com-
pared to 13 or 26 weeks of age) of both genotypes
separately using one-way ANOVAs with Tukey post-
hoc test (Graph Pad InStat version 3.05: Graph Pad
Software, San Diego, CA, USA; www.graphpad.com).
In addition, the micro-CT parameters, histomorpho-
metric data, femur length, ultimate load, bone resorp-
tion data, and parameters of cell culture analyses were
compared between genotypes for all age groups
separately using two-tailed unpaired t-tests.
Results
To study the bone phenotype in normal and premature
aging female TTD mice, we performed a systematic
cohort study including eight mice per age group per
genotype. A previous study, performed on a hybrid
C57BL/6J 129ola genetic background, showed that
TTD mice live shorter than wild-type mice (de Boer et
al. 2002). In the present study, we were able to analyse
13-, 26-, 39-, 52-, 65- and 78-week-old wild-type
and TTD mice in a homogeneous C57Bl/6 genetic
background. For wild-type control mice, we could
in addition analyse 91- and 104-week-old mice.
Bone geometry
First, 3D thickness distribution was analyzed using
μCT. In tibiae from wild-type mice, a gradual
progressive decline in 3D thickness distribution was
observed with age (Fig. 1a). In TTD mice, this
process was accelerated with a severe decrease in
3D thickness distribution after 39 weeks of age
(Fig. 1b). Already at 52 weeks of age, 3D thickness
distribution in TTD tibiae reached a level that in wild-
type mice was only reached at 91 weeks of age
(Fig. 1c). Thus age-related decrease in bone mass
occurred earlier in TTD mice than in wild-type mice.
To study this difference in onset of decrease in
bone mass in more detail, we analyzed specific μCT
parameters. In wild-type mice, cortical bone volume
gradually decreased with age, only reaching signifi-
cance at 104 weeks of age at which time a 12%
decrease in bone volume compared to 26-week-old
wild-type bones was observed (Fig. 1d). At 26 and
39 weeks of age, tibiae of TTD mice had a bone
volume similar to that of wild-type mice (Fig. 1d).
However, in the period thereafter, bone volume
rapidly decreased to 31% (78-week-old TTD mice
dropping to 69% of the bone volume of 26-week-old
TTD mice), which was significantly lower than the
9% decline in age-matched wild-type mice at
78 weeks of age (Fig. 1d). Already at 52 weeks of
age TTD mice reached a cortical bone volume
comparable to that of 104-week-old wild-type mice
(Fig. 1d). In line with cortical bone volume, wild-type
tibiae maintained their cortical thickness up to
78 weeks of age and showed a decrease thereafter
while TTD tibiae already displayed a rapid drop in
cortical thickness after 39 weeks of age resulting in a
significantly thinner cortex in TTD mice (Fig. 1e).
Next, we analyzed the bone perimeter. As depicted
in Fig. 1f, tibiae from young mice had a similar
perimeter (at 26 weeks: 5.80 mm in wild-type mice
and 5.96 mm in TTD mice), again indicating normal
bone development in TTD mice. From 52 weeks
onwards, wild-type tibiae showed a progressive
increase in perimeter reaching 6,33 mm at 78 weeks
(9% increase) and 6.78 mm at 104 weeks (17%
increase). In contrast, TTD mice failed to show an
increase in perimeter (5.88 mm at 78 weeks). In 78-
week-old wild-type mice, the perimeter is significantly
higher compared to TTD mice (Fig. 1f). Thus, TTD
mice lack the age-related increase in perimeter as seen
in wild-type tibiae (Fig. 1f).
The endocortical volume was larger in TTD than
in wild-type mice in the early phase of life but later
in life endocortical volume in wild-type mice
increased and becomes equal to that of TTD mice
(Fig. 1g). The temporal dynamics in endocortical
volume in wild-type mice, showing an increase after
52 weeks, match that observed for perimeter,
showing an increase from 52 weeks of age onwards.
However, periosteal apposition could no longer
match the endocortical bone loss in wild-type mice
after 78 weeks of age leading to a decrease in
cortical thickness (Fig. 1e).
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Fig. 1 Thickness distribution and cortical bone parameters in
wild-type and TTD mice. Cortical thickness distribution in
aging wild-type (a) and TTD mice (b) with the arrow indicating
the direction of change with aging. Comparison of thickness
distribution in 52-week-old TTD mice (dotted line) compared
to 91-week-old wild-type mice (solid line) (c). Bone parameters
in aging wild-type mice (solid triangles) and TTD mice (open
triangles): cortical bone volume (d), cortical thickness (e),
perimeter (f) and endocortical volume (g). TTD mice compared
to wild-type animals: #p<0.05, ##p<0.01, ###p<0.001; TTD
mice and wild-type animals compared to their 26-week time
point: *p<0.05, **p<0.01, ***p<0.001; error bars represent
SEM
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Next, we analyzed trabeculae in the metaphyseal
area. Aging wild-type mice showed a gradual decrease
in both BV/TV and trabecular number (Fig. 2a and b)
while trabecular thickness showed a mild increase with
aging (Fig. 2c). Overall, no significant differences
between wild-type and TTD mice were observed. In
contrast to wild-type mice, the trabecular bone in TTD
mice showed a remarkable dynamic pattern around
39 weeks of age as exemplified by a transient non-
significant increase in BV/TV, trabecular number and
trabecular thickness (Fig. 2a, b and c).
Histomorphometric analysis
In order to analyze the lack of periosteal expansion in
TTD mice in more detail, we examined endosteal and
periosteal bone apposition by double labeling studies. In
wild-type mice both periosteal and endosteal bone
formation were present throughout life (Fig. 3a). In
contrast, in TTD mice endosteal apposition was present
whereas periosteal apposition was virtually absent in
older TTD mice (Fig. 3a). Quantitative analyses
revealed no significant difference in endosteal bone
formation between 13-week-old wild-type and TTD
mice (Fig. 3b). At 39 weeks of age, endosteal bone
formation was significantly decreased in TTD mice
compared to wild-type mice, but after 39 weeks of age
endosteal bone formation decreased in wild-type mice
as well (Fig. 3b). At 78 weeks of age, wild-type and
TTD mice showed a 20–25% decrease in endosteal
bone formation when compared to 13-week-old ani-
mals. At 13 weeks of age, periosteal apposition showed
no significant difference between wild-type and TTD
mice (Fig. 3c). However, after 13 weeks of age, TTD
mice showed a dramatic and significant decrease in
periosteal apposition compared to wild-type mice
(Fig. 3c). Only at 78 weeks of age, when periosteal
apposition in wild-type mice decreased as well, there
was no significant difference compared to TTD mice
anymore (Fig. 3c). At that time, however, TTD mice
exhibited a 60% decrease in periosteal apposition
compared to a 25% decrease in wild-type mice when
compared to 13-week-old animals. Osteocytes in
cortical sections of tibiae of wild-type and TTD mice
were measured to assess whether a reduced number of
osteocytes in TTD mice could play a role in impaired
periosteal apposition. However, no significant differ-
ence in the number of osteocytes was found between
wild-type and TTD mice or in aging animals (data not
shown). In addition, we analyzed the number of
osteoblasts, osteoclasts and osteoid volume. The num-
ber of osteoblasts did not show a significant difference
between wild-type and TTD tibiae at the analyzed ages
(Fig. 3d). However, there was a significance difference
in number of osteoblasts over life (p=0.03, Kruskal–
Wallis test). No significant difference in the number of
Fig. 2 Trabecular bone parameters in wild-type and TTD mice.
Bone parameters measured in 100 cross-sections in the
metaphysis of aging wild-type mice (solid triangles) and TTD
mice (open triangles): a trabecular bone volume fraction (BV/
TV), b trabecular number and c trabecular thickness. Wild-type
animals compared to their 26-week time point: *p<0.05; error
bars represent SEM
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Fig. 3 Histomorphometric analysis and backscatter scanning
electron microscopy of wild-type and TTD mice. Calcein double
labeling of endosteal and periosteal bone formation in wild-type
and TTD mice (a). Quantified endosteal apposition (b), quanti-
fied periosteal apposition (c), number of osteoblasts (d), number
of osteoclasts (e) and osteoid volume (f) and mineralization
status (g) in wild-type (solid symbols) and TTD (open symbols)
mice. TTD mice compared to wild-type mice: #p<0.05, ###p<
0.001; TTD mice compared to their 13-week time point: *p<
0.05, **p<0.01, ***p<0.001; error bars represent SEM
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osteoclasts was observed between wild-type and TTD
mice or in aging animals (Fig. 3e). Osteoid volume
seemed to decrease with age in both wild-type and
TTD tibiae, but at none of the ages osteoid volume was
significantly different between wild-type and TTD
mice (Fig. 3f). Osteoid surface showed similar results
(data not shown). These osteoid data exclude that the
differences observed by μCT are due to a mineralization
defect. This is further supported by quantitative back-
scatter scanning electron microscopy showing no signif-
icant differences in degree of mineralization (Fig. 3g).
Mechanical testing of bone strength
The overall picture that emerges is that compared to
wild-type mice, aging TTD mice show an accelerated
decrease in bone mass, which initiated between weeks
39 and 52, and that TTD mice lack the age-related
increase in perimeter. To analyze the consequence of
these geometric changes, we calculated the polar
moment of inertia, which is a measure of the geometrical
distribution and a proxy for mechanical stiffness and
strength per transversal cross-section. This demonstrat-
ed that tibiae from wild-type mice maintained polar
moment of inertia at a constant level throughout life,
even at 91 and 104 weeks of age when bone volume and
cortical thickness were reduced (Fig. 4a). In contrast,
TTD tibiae failed to maintain the polar moment of
inertia and even showed a progressive decrease
throughout life starting at 39 weeks of age (Fig. 4a),
i.e., 78-week-old TTD mice showed a 65% decrease in
moment of inertia compared to 39-week-old TTD mice
whereas the moment of inertia in 78-week-old wild-
type mice showed a 106% increase compared to 39-
week-old wild-type mice.
Using a three-point bending assay, we tested
whether the differences in polar moment of inertia
and lack of periosteal apposition in TTD mice
resulted in a difference in bone strength. Femurs from
wild-type and TTD mice showed a comparable and
increasing ultimate fracture load up to 26 weeks of
age (Fig. 4b). After 26 weeks there was a progressive
decrease in ultimate fracture load in both genotypes
but this was clearly more prominent and significant in
TTD mice showing a 50% decline compared to a 25%
decline in wild-type mice (Fig. 4b). Femurs of TTD
mice fractured at a lower ultimate load than femurs of
wild-type mice, which reached significance in 52- and
78-week-old animals.
Bone resorption
In wild-type and TTD mice, the levels of TRAP were
measured to assess whether differences in bone
resorption could explain the observed morphometric
differences. As expected, bone resorption seemed to
increase with aging in both wild-type and TTD mice
(Fig. 4c). In addition, TTD seemed to have higher
levels of TRAP. However, no significant differences
were observed between genotypes or with age.
Fig. 4 Mechanical testing and TRAP assay in wild-type and
TTD mice. Polar moment of inertia in tibiae (a), ultimate load
applied on femurs (b), serum TRAP levels (c), of wild-type
(solid symbols) and TTD (open symbols) mice. TTD mice
compared to wild-type animals: #p<0.05, ###p<0.001; TTD and
wild-type mice compared to their 26-week time point: *p<0.05,
***p<0.001; error bars represent SEM
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Bone marrow cell cultures
To assess whether the differences in bone phenotype
in TTD mice are due to an impaired osteoblast and/or
osteoclast differentiation, we performed bone marrow
cultures and assessed the capacity to form osteoblasts
and adipocytes from mesenchymal stem cells as well
as osteoclasts from hematopoietic stem cells for wild-
type and TTD mice of various ages. The number of
TRAP-positive osteoclasts was similar in 13-week-old
wild-type and TTD cultures (Fig. 5a). In the following
period, wild-type, but not TTD, mice showed a
significant decline in the number of osteoclasts
resulting in a significant higher number of osteoclasts
at 26 weeks of age in TTD mice. At later ages the
number of osteoclasts was similar in wild-type and
TTD mice (Fig. 5a). The amount of resorption by
mature osteoclasts was not significantly different
between wild-type and TTD mice (Fig. 5b). At
13 weeks of age, the number of bone nodules was
similar for wild-type and TTD mice (Fig. 5c).
However, the number of bone nodules in TTD mice
showed a rapid decline resulting in significantly lower
numbers of bone nodules at 26 and 39 weeks of age
compared to wild-type mice (Fig. 5c). Subsequently,
the number of bone nodules in wild-type mice also
Fig. 5 Stem cell cultures of wild-type and TTD mice. Analyses
of osteoclast, osteoblast and adipocyte differentiation capacity
in bone marrow cell cultures in wild-type (solid bars) and TTD
mice (open bars). Number of TRAP-positive osteoclasts (a),
resorption surface per mature osteoclast (b), number of alkaline
phosphatase-positive bone nodules (c), size of alkaline
phosphatase-positive bone nodules (d) and number of adipo-
cytes (e). TTD mice compared to wild-type animals: #p<0.05,
###p<0.001; error bars represent SEM
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declined resulting in similar numbers as in 45-week-old
TTD mice (Fig. 5c). There was no significant differ-
ence in bone nodule size between wild-type and TTD
mice at any age (Fig. 5d). Both wild-type and TTD
nodules mineralized, but no significant differences
between the genotypes could be detected at any age
(data not shown). Similarly, both wild-type and TTD
mice were able to form adipocytes but no significant
differences between the genotypes could be detected at
any age (Fig. 5e).
PTH treatment
Albeit with an accelerated decrease in bone nodule
formation, the bone marrow cultures of TTD mice
retained their capacity to generate osteoblasts and
form bone. To investigate whether this bone forming
capacity is still present and can be stimulated in vivo
as well, we analyzed the effect of intermittent PTH
treatment on bone structure in TTD mice. PTH
treatment was started at 45 weeks of age, i.e., after
the accelerated bone loss has started. Cortical bone
volume showed an increase after 20 weeks intermittent
PTH treatment as can be seen from the right shift in the
3D-thickness distribution (Fig. 6c). PTH treatment
significantly increased trabecular bone volume fraction,
trabecular thickness as well as cortical thickness
suggesting that osteoblasts in TTD mice can still be
stimulated to increase bone formation (Fig. 6a, b and d).
Discussion
TTD mice display features of premature aging in
many organs and tissues (de Boer et al. 2002;
Wijnhoven et al. 2005), but the progeroid symptoms
do not affect all tissues to the same extent. In fact,
paradoxically, a detailed, systematic large cohort
analysis revealed that some organs and tissues even
exhibit features resembling caloric restriction and
delayed aging. For instance, the occurrence of cataract
in the eyes in TTD mice was found to be significantly
less compared to the isogenic wild-type control mice
kept under the same conditions (Wijnhoven et al.
2005). This extends the notion that all human progeroid
syndromes are segmental (Martin 2005), i.e., that
multiple organs suffer from rapid aging, yet others
seem relatively unaffected and as shown by TTD mice
may even age slower than wild-type controls. Micro-
array expression analysis of various accelerated aging
mice revealed a strong parallel with expression profiles
of normal aging (Niedernhofer et al. 2006; van der
Pluijm et al. 2007). To examine at the level of
physiology, whether TTD mice are indeed a bona fide
model for aging and to rule out that it is a developmental
disorder, we examined in great detail the effect of aging
on bone parameters of female wild-type mice as well as
progeroid TTD mice. The systematic analysis uncov-
ered the consequence of a defect in DNA repair and
basal transcription on the velocity of age-related skeletal
Fig. 6 PTH treatment in
TTD mice. a Trabecular
bone volume fraction (BV/
TV), b trabecular thickness,
c cortical thickness distribu-
tion and d cortical thickness
in femora from PTH treated
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changes and assessed to which extent the skeletal
abnormalities reflect normal bone aging.
Normal skeletal development but accelerated skeletal
aging in progeroid TTD mice
It should be emphasized that by all parameters
measured bone develops normally in TTD female
mice, i.e., bone volume, cortical thickness and
perimeter are similar in wild-type and TTD mice up
to 39 weeks of age. In addition, similar numbers of
osteoblasts and osteoclasts in bone marrow cultures as
well as periosteal apposition are present up to at least
13 weeks of age. This observation excludes a
developmental defect as explanation for the TTD
phenotype and is in line with other studies on TTD
mice (Wijnhoven et al. 2005).
After 39 weeks of age profound accelerated decrease
in bone volume is observed in TTD mice. The decrease
in bone volume and cortical thickness in TTD mice is
almost 40 weeks ahead of that in wild-type mice. This
accelerated form of natural bone aging strongly under-
lines the premature aging phenotype of TTD mice.
Notably, the decrease in bone volume is paralleled
by an accelerated decrease in bone strength in TTD
mice after 26 weeks of age, i.e., an ultimate fracture
load as observed in 52-week-old TTD mice was only
noticed in 104-week-old wild-type mice (Fig. 4b). An
important mechanism underlying the accelerated
decrease in bone strength is that in TTD mice the
larger endocortical volume is not compensated by an
increase in age-related periosteal apposition and
perimeter as seen in wild-type mice. The accelerated
decrease in bone strength cannot be explained by a
change in mineralization grade of the matrix as
assessed by quantitative backscatter scanning electron
microscopy analyses or increased bone resorption as
assessed by measurement of serum TRAP.
Lack of periosteal apposition as a cause of decreased
bone strength in TTD mice
The lack of effective periosteal apposition in TTD
mice is intriguing as it is a localized phenomenon.
Despite the important role of periosteal apposition in
establishing structural strength during growth and in
maintaining strength during aging, little is known
about the mechanism and control of periosteal
apposition (Seeman 2003b). Currently, it is tempting
to speculate that, with aging, increased bending stress
on the outer surface of bone (due to endosteal bone
loss and subsequent cortical thinning) leads to the
stimulation of periosteal bone apposition (Akhter et
al. 2002; Beck et al. 2001; Lazenby 1990). The force
of mechanical bending and torsion varies linearly
with the distance from the neutral axis and therefore
bending stress is larger on the periosteal side of the
bone (Currey 1999). Mechanical loading could thus
influence periosteal apposition and a change in
mechanical loading could consequently affect this
process. In wild-type mice, we see the natural link
between thinning of the cortex, increase in endocort-
ical volume, the presence of periosteal apposition and
increase in perimeter. In TTD mice this increase in
perimeter is absent. As TTD mice, in contrast to wild-
type mice do not accumulate fat with aging, the
difference in weight (Wijnhoven et al. 2005) might
contribute to the difference in periosteal apposition.
However, we could not detect an obvious correlation
between body weight and perimeter (unpublished
observations). Moreover, in mice a relationship
between body weight and femur, vertebral and
phalangeal bone parameters has not been found
(Beamer et al. 1996). TTD mice may provide an
excellent tool to study periosteal apposition and to
unravel the underlying mechanisms.
DNA repair defect and bone marrow stem cells
in TTD mice
With regard to the accelerated decrease in bone
formation and bone mass, the deficiency of DNA
damage repair is very likely to have a causative effect.
DNA lesions (e.g., induced by free radicals), which
are a by-product of normal metabolism, are incom-
pletely repaired by DNA-repair deficient TTD mice
(de Boer et al. 2002). The increased damage load will
lead to dysfunctional senescent cells or will cause
apoptosis (Campisi 2005). Indeed, TTD mice appear
to exhibit a decreased spontaneous tumor formation
rate likely at least in part by an increased rate of
apoptosis (de Boer and Hoeijmakers 1999; Wijnhoven
et al. 2005), which protects from cancer but at the
same time likely accelerates aging. An increased rate
of apoptosis can therefore be expected to cause
accelerated depletion of stem cells or early progenitor
cells leading to a disturbed osteoblasts and adipocyte
differentiation from mesenchymal stem cells and
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osteoclasts derived from the hematopoietic stem cell
lineage. A decrease in mesenchymal stem cell number
or disturbed differentiation is suggested by the fact
that TTD mice lack abdominal fat mass (Compe et al.
2005). As the structural differences in bone became
apparent after 39 weeks we analyzed bone marrow
mesenchymal and hematopoietic stem cell differentia-
tion in the period around this age starting at 13 weeks of
age. Osteogenic analyses of the bone marrow cultures
demonstrated an accelerated decrease in bone nodule
formation implicating an accelerated reduction in the
number of mesenchymal stem cells that can differentiate
into osteoblasts that precedes the decrease in bone mass.
The absence of differences in size of the bone nodules
shows that the proliferative capacity of the stem cells
present is not changed in TTD mice. Histomorphomet-
ric analyses showed that the number of osteoblasts in
vivo was lower in tibia of TTD mice throughout life.
These data suggest that DNA damage levels in TTD
mice reach a critical threshold in (mesenchymal) stem
cells between 13 and 26 weeks, which translates into
reduced numbers of differentiated osteoblasts and a
bone phenotype. Although we only studied bone
marrow cultures up to 45 weeks, bone nodule formation
in wild-type mice seems to decrease starting at 45 weeks
of age, which is in line with the observed significant
decrease in the number of osteoblasts in wild-type tibiae
at 52 weeks of age. It was shown previously that old
mice had significantly fewer stem cells with osteogenic
potential than young animals (Bergman et al. 1996;
Moerman et al. 2004). In humans, the number of stem
cells with osteogenic potential was shown to decrease
already at young age (D'Ippolito et al. 1999; Nishida et
al. 1999; Zhou et al. 2008). Only at 26 weeks of age a
drop in the number of osteoclasts observed in wild-
type mice leads to a significant difference in in vitro
osteoclast formation between wild-type and TTD mice
while no significant differences in resorption capacity
were observed. The decreased osteoblast differentiation
at 26 weeks of age may explain the decrease in bone
volume and structure as first observed after 39 weeks.
Obviously, definite proof that the observed accelerated
decrease in mesenchymal stem cells in TTD mice is
due to accumulation of DNA damage as a consequence
of deficient DNA repair is lacking and, with current
technology, very difficult to obtain. However, the most
plausible scenario is that loss of DNA repair indeed
leads to accumulation of otherwise repaired DNA
lesions, which triggers cell death and cellular senes-
cence. In the case of bone metabolism, this results in
an accelerated decrease in mesenchymal stem cells,
suppression of growth and differentiation, deranged
bone metabolism and inevitably premature loss of
bone strength. Although there is an accelerated
decrease in bone nodule formation, the current data
show that TTD bone marrow mesenchymal stem cells
retain bone forming capacity. This is further substanti-
ated by the in vivo intermittent PTH treatment studies.
Intermittent PTH administration to TTD mice demon-
strated an increase in cortical thickness implicating that
the stem cells/osteoblasts can still be stimulated to form
bone. Considering the above-mentioned relationship
between DNA repair and apoptosis, it is interesting to
note that PTH has been reported to inhibit osteoblast
apoptosis (Jilka et al. 1999; Sowa et al. 2003). The
PTH effect on cortical thickness in TTD mice appears
to be the result of increased endosteal bone formation
and not periosteal apposition, as perimeter was not
significantly changed. Interestingly, a recent study
showed differences in mechanism by which intermit-
tent PTH treatment increases bone formation at the
endosteal and at the periosteal surface (Jilka et al.
2009). The increase in endocortical osteoblasts after
intermittent PTH treatment is predominantly due to
attenuated osteoblast apoptosis (Jilka et al. 2009). In
periosteal bone where the rate of osteoblast apoptosis
is low, PTH does not increase the number of
osteoblasts by attenuating apoptosis, but by exerting
pro-differentiating and/or pro-survival effects on post-
mitotic pre-osteoblasts (Jilka et al. 2009). These data
are suggestive for different age-related mechanisms at
the endosteal and periosteal level and in line with our
hypothesis that increased apoptosis of osteoprogenitors
contributes to the decreased periosteal apposition in
TTD mice. The adipocyte cultures support the fact that
the intrinsic differentiation capacity of mesenchymal
stem cells is not affected. In vivo TTD mice lack fat
accumulation, but in vitro normal adipocyte differen-
tiation is observed. Overall, these observations point to
an altered systemic environment in TTD mice.
Currently, it should be concluded that the observed
accelerated skeletal aging observed in TTD mice is the
result from a combination of an accelerated decline in
the number of osteogenic stem cells together with
altered systemic influences.
In conclusion, we demonstrate that the increased
and accelerated decrease in bone mass in DNA repair-
deficient TTD mice is a premature aging feature,
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which implies that the other aging-like features in TTD
mice and patients may also represent bona fide
premature aging symptoms and which in a broader
context substantiates the importance of DNA repair in
healthy aging. The TTD mouse mutant constitutes a
valid model for bone aging and the absence of periosteal
apposition provides for identification of new targets for
maintaining bone strength with aging.
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